Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation

Completed

• Conditions: Paroxysmal Atrial Fibrillation

• Registration Number: NCT01789372
• Lead Sponsor: Danderyd Hospital

Brief Summary

The purpose of this study is to determinate if mediyoga has effects in quality of life, heart rate variability, blood pressure , heart rate in patients with paroxysmal atrial fibrillation (PAF).

Detailed Description

This is randomized prospective pilot study. Eighty patients from Danderyd hospital, Stockholm, Sweden were randomized to either mediyoga group or control group. The mediyoga group were completing yoga for one hour, once a week for 12 weeks together with usual treatment. The controlgroup had only usual treatment.The usual treatment consists of pharmaceutical, cardio version and ablation. Quality of life ( SF-36, EQ-5d), blood pressure, heart rate and 24-hours ekokardiografi were measured at baseline and after twelve weeks.A follow up after six months was accomplished with SF-36 and EQ-5d, bloodpressure and heart rate.

Study Timeline

• Study Start: 2009-12
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Status Verified: 2013-02
• Study First Submitted: 2013-02-05
• Study First Submitted QC: 2013-02-11
• Last Update Submitted: 2013-02-11
• Study First Posted: 2013-02-12
• Last Update Posted: 2013-02-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Diagnosis of PAF

Exclusion Criteria

• The exclusions criteria were multiple concurrent medical conditions and/or cognitive dysfunction (in the diagnosis of e.g. mental illness), considered not to be able to carry out yoga owing to ability to move and those who have difficulties to understand the Swedish language.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life	Change from baseline in SF-36 after 12 weeks.Change from baseline in EQ-5D after six month

Secondary Outcome Measures

Name	Time	Method
Blood pressure	Change from baseline in blood pressure after 12 weeks. Change from baseline in blood pressure after six months
heart rate	Change from baseline in heart rate after 12 weeks.Change from baseline in heart rate after six months.
Heart variability	Change from baseline in heart variability after 12 weeks.Change from baseline in heart variability after six months.

Trial Locations

Locations (1)

Danderyds hospital; 🇸🇪 Stockholm, Sweden